Dynatronics (DYNT) Competitors $0.14 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends DYNT vs. HSCS, SINT, BBLG, HSDT, NAOV, AVGR, NUWE, BIOL, SDCCQ, and IONMShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Heart Test Laboratories (HSCS), Sintx Technologies (SINT), Bone Biologics (BBLG), Helius Medical Technologies (HSDT), NanoVibronix (NAOV), Avinger (AVGR), Nuwellis (NUWE), BIOLASE (BIOL), SmileDirectClub (SDCCQ), and Assure (IONM). These companies are all part of the "medical equipment" industry. Dynatronics vs. Heart Test Laboratories Sintx Technologies Bone Biologics Helius Medical Technologies NanoVibronix Avinger Nuwellis BIOLASE SmileDirectClub Assure Dynatronics (NASDAQ:DYNT) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations. Do analysts rate DYNT or HSCS? Heart Test Laboratories has a consensus target price of $15.00, indicating a potential upside of 417.24%. Given Heart Test Laboratories' higher probable upside, analysts clearly believe Heart Test Laboratories is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AHeart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in DYNT or HSCS? 4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 17.2% of Heart Test Laboratories shares are owned by institutional investors. 9.1% of Dynatronics shares are owned by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is DYNT or HSCS more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Dynatronics' net margin of -8.29%. Dynatronics' return on equity of -37.01% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Dynatronics-8.29% -37.01% -9.52% Heart Test Laboratories N/A -144.12%-94.48% Does the media favor DYNT or HSCS? In the previous week, Dynatronics had 1 more articles in the media than Heart Test Laboratories. MarketBeat recorded 1 mentions for Dynatronics and 0 mentions for Heart Test Laboratories. Dynatronics' average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score. Company Overall Sentiment Dynatronics Neutral Heart Test Laboratories Neutral Which has higher valuation & earnings, DYNT or HSCS? Dynatronics has higher revenue and earnings than Heart Test Laboratories. Dynatronics is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDynatronics$32.53M0.03-$2.70M-$0.99-0.14Heart Test Laboratories$20K131.95-$6.61M-$21.64-0.13 Does the MarketBeat Community prefer DYNT or HSCS? Dynatronics received 305 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 80.00% of users gave Heart Test Laboratories an outperform vote while only 49.05% of users gave Dynatronics an outperform vote. CompanyUnderperformOutperformDynatronicsOutperform Votes30949.05% Underperform Votes32150.95% Heart Test LaboratoriesOutperform Votes480.00% Underperform Votes120.00% Which has more volatility and risk, DYNT or HSCS? Dynatronics has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 3.16, meaning that its share price is 216% more volatile than the S&P 500. SummaryDynatronics and Heart Test Laboratories tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$995,000.00$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E Ratio-0.1437.84113.7615.14Price / Sales0.0364.751,483.0493.53Price / CashN/A49.2739.7134.04Price / Book0.124.214.665.01Net Income-$2.70M$11.52M$119.06M$225.46M7 Day PerformanceN/A1.05%0.79%0.37%1 Month Performance2.22%0.94%5.65%3.57%1 Year Performance-73.68%39.40%36.80%29.42% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.14flatN/A-73.4%$995,000.00$32.53M-0.14200Analyst ForecastGap DownHSCSHeart Test Laboratories3.217 of 5 stars$3.10-4.3%$15.00+384.2%-87.4%$2.03M$18,600.00-0.1410Positive NewsSINTSintx Technologies1.0549 of 5 stars$3.21+0.9%N/A-96.5%$1.97M$1.44M-0.0243News CoveragePositive NewsBBLGBone Biologics0.805 of 5 stars$1.73+0.6%N/A-69.3%$1.90MN/A0.002Gap DownHSDTHelius Medical Technologies1.7125 of 5 stars$0.49-9.2%$24.00+4,773.1%-93.4%$1.76M$640,000.00-0.0530NAOVNanoVibronix0.1035 of 5 stars$0.55+5.8%N/A-30.1%$1.52M$2.28M-0.4220Gap UpAVGRAvinger2.8848 of 5 stars$0.83-4.6%$5.00+502.4%-77.7%$1.41M$7.43M-0.0770Upcoming EarningsAnalyst ForecastNUWENuwellis2.243 of 5 stars$1.86+13.4%$17.00+814.0%-94.6%$960,000.00$9.01M-0.0159News CoverageBIOLBIOLASE1.1392 of 5 stars$0.01flat$1.20+14,017.6%-99.7%$284,000.00$48.83M0.00160News CoverageGap DownSDCCQSmileDirectClubN/A$0.00flatN/A-99.5%$121,000.00$470.74M0.002,700Gap DownIONMAssureN/A$0.11flatN/A-97.6%$66,000.00$149,000.000.00130 Related Companies and Tools Related Companies Heart Test Laboratories Competitors Sintx Technologies Competitors Bone Biologics Competitors Helius Medical Technologies Competitors NanoVibronix Competitors Avinger Competitors Nuwellis Competitors BIOLASE Competitors SmileDirectClub Competitors Assure Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DYNT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
